APO RESEARCH · REPORT
MIS Sacroiliac Joint Fusion
Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time. Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.
Product & engineering
Understand the product.
Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time. Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.
Selected research
Market Outlook & Growth Opportunities
Global MIS Sacroiliac Joint Fusion Market Outlook and Growth Opportunities 2026
Market perspective
Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time. Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.
North America is the largest Asphalt Anti-strip Promoters market with about 65% market share. Europe is follower, accounting for about 19% market share.
The key players are SI-BONE, Medtronic, Zimmer Biomet, Orthofix, Zyga Technology, Xtant Medical, Globus Medical, Life Spine, CoreLink, VGI Medical, SIGNUS Medizintechnik etc. Top 3 companies occupied about 65% market share.
Read the full market overview
This report provides an overview of the global MIS Sacroiliac Joint Fusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of MIS Sacroiliac Joint Fusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents MIS Sacroiliac Joint Fusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the MIS Sacroiliac Joint Fusion market size, projected growth trends, production technologies, key applications, and end-use industries.
MIS Sacroiliac Joint Fusion Segment by Company
SI-BONE
Medtronic
Zimmer Biomet
Orthofix
Zyga Technology
Xtant Medical
Globus Medical
Life Spine
CoreLink
VGI Medical
SIGNUS Medizintechnik
MIS Sacroiliac Joint Fusion Segment by Type
Minimally Invasive Surgery
Open Surgery of Sacroiliac Joint Fusion
MIS Sacroiliac Joint Fusion Segment by Application
Hospitals
ASC
MIS Sacroiliac Joint Fusion Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global MIS Sacroiliac Joint Fusion status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions MIS Sacroiliac Joint Fusion market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify MIS Sacroiliac Joint Fusion significant trends, drivers, influence factors in global and regions.
6. To analyze MIS Sacroiliac Joint Fusion competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MIS Sacroiliac Joint Fusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MIS Sacroiliac Joint Fusion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MIS Sacroiliac Joint Fusion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the MIS Sacroiliac Joint Fusion market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global MIS Sacroiliac Joint Fusion industry.
Chapter 3: Detailed analysis of MIS Sacroiliac Joint Fusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of MIS Sacroiliac Joint Fusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of MIS Sacroiliac Joint Fusion in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Minimally Invasive Surgery
- Open Surgery of Sacroiliac Joint Fusion
Applications
- Hospitals
- ASC
Companies covered
- SI-BONE
- Medtronic
- Zimmer Biomet
- Orthofix
- Zyga Technology
- Xtant Medical
- Globus Medical
- Life Spine
- CoreLink
- VGI Medical
- SIGNUS Medizintechnik
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 1.2.2 Global MIS Sacroiliac Joint Fusion Sales Volume (2021-2032)
- 1.2.3 Global MIS Sacroiliac Joint Fusion Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 MIS Sacroiliac Joint Fusion Market Dynamics
- 2.1 MIS Sacroiliac Joint Fusion Industry Trends
- 2.2 MIS Sacroiliac Joint Fusion Industry Drivers
- 2.3 MIS Sacroiliac Joint Fusion Industry Opportunities and Challenges
- 2.4 MIS Sacroiliac Joint Fusion Industry Restraints
3 MIS Sacroiliac Joint Fusion Market by Company
- 3.1 Global MIS Sacroiliac Joint Fusion Company Revenue Ranking in 2025
- 3.2 Global MIS Sacroiliac Joint Fusion Revenue by Company (2021-2026)
- 3.3 Global MIS Sacroiliac Joint Fusion Sales Volume by Company (2021-2026)
- 3.4 Global MIS Sacroiliac Joint Fusion Average Price by Company (2021-2026)
- 3.5 Global MIS Sacroiliac Joint Fusion Company Ranking (2024-2026)
- 3.6 Global MIS Sacroiliac Joint Fusion Company Manufacturing Base and Headquarters
- 3.7 Global MIS Sacroiliac Joint Fusion Company Product Type and Application
- 3.8 Global MIS Sacroiliac Joint Fusion Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global MIS Sacroiliac Joint Fusion Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 MIS Sacroiliac Joint Fusion Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 MIS Sacroiliac Joint Fusion Market by Type
- 4.1 MIS Sacroiliac Joint Fusion Type Introduction
- 4.1.1 Minimally Invasive Surgery
- 4.1.2 Open Surgery of Sacroiliac Joint Fusion
- 4.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Type
- 4.2.1 Global MIS Sacroiliac Joint Fusion Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Type (2021-2032)
- 4.2.3 Global MIS Sacroiliac Joint Fusion Sales Volume Share by Type (2021-2032)
- 4.3 Global MIS Sacroiliac Joint Fusion Sales Value by Type
- 4.3.1 Global MIS Sacroiliac Joint Fusion Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global MIS Sacroiliac Joint Fusion Sales Value by Type (2021-2032)
- 4.3.3 Global MIS Sacroiliac Joint Fusion Sales Value Share by Type (2021-2032)
5 MIS Sacroiliac Joint Fusion Market by Application
- 5.1 MIS Sacroiliac Joint Fusion Application Introduction
- 5.1.1 Hospitals
- 5.1.2 ASC
- 5.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Application
- 5.2.1 Global MIS Sacroiliac Joint Fusion Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Application (2021-2032)
- 5.2.3 Global MIS Sacroiliac Joint Fusion Sales Volume Share by Application (2021-2032)
- 5.3 Global MIS Sacroiliac Joint Fusion Sales Value by Application
- 5.3.1 Global MIS Sacroiliac Joint Fusion Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global MIS Sacroiliac Joint Fusion Sales Value by Application (2021-2032)
- 5.3.3 Global MIS Sacroiliac Joint Fusion Sales Value Share by Application (2021-2032)
6 MIS Sacroiliac Joint Fusion Regional Sales and Value Analysis
- 6.1 Global MIS Sacroiliac Joint Fusion Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global MIS Sacroiliac Joint Fusion Sales by Region (2021-2032)
- 6.2.1 Global MIS Sacroiliac Joint Fusion Sales by Region: 2021-2026
- 6.2.2 Global MIS Sacroiliac Joint Fusion Sales by Region (2027-2032)
- 6.3 Global MIS Sacroiliac Joint Fusion Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global MIS Sacroiliac Joint Fusion Sales Value by Region (2021-2032)
- 6.4.1 Global MIS Sacroiliac Joint Fusion Sales Value by Region: 2021-2026
- 6.4.2 Global MIS Sacroiliac Joint Fusion Sales Value by Region (2027-2032)
- 6.5 Global MIS Sacroiliac Joint Fusion Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 6.6.2 North America MIS Sacroiliac Joint Fusion Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 6.7.2 Europe MIS Sacroiliac Joint Fusion Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 6.8.2 Asia-Pacific MIS Sacroiliac Joint Fusion Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 6.9.2 South America MIS Sacroiliac Joint Fusion Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa MIS Sacroiliac Joint Fusion Sales Value (2021-2032)
- 6.10.2 Middle East & Africa MIS Sacroiliac Joint Fusion Sales Value Share by Country, 2025 VS 2032
7 MIS Sacroiliac Joint Fusion Country-level Sales and Value Analysis
- 7.1 Global MIS Sacroiliac Joint Fusion Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global MIS Sacroiliac Joint Fusion Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global MIS Sacroiliac Joint Fusion Sales by Country (2021-2032)
- 7.3.1 Global MIS Sacroiliac Joint Fusion Sales by Country (2021-2026)
- 7.3.2 Global MIS Sacroiliac Joint Fusion Sales by Country (2027-2032)
- 7.4 Global MIS Sacroiliac Joint Fusion Sales Value by Country (2021-2032)
- 7.4.1 Global MIS Sacroiliac Joint Fusion Sales Value by Country (2021-2026)
- 7.4.2 Global MIS Sacroiliac Joint Fusion Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.5.2 USA MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.9.2 France MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.16.2 China MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.19.2 India MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt MIS Sacroiliac Joint Fusion Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt MIS Sacroiliac Joint Fusion Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt MIS Sacroiliac Joint Fusion Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SI-BONE
- 8.1.1 SI-BONE Company Information
- 8.1.2 SI-BONE Business Overview
- 8.1.3 SI-BONE MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.1.4 SI-BONE MIS Sacroiliac Joint Fusion Product Portfolio
- 8.1.5 SI-BONE Recent Developments
- 8.2 Medtronic
- 8.2.1 Medtronic Company Information
- 8.2.2 Medtronic Business Overview
- 8.2.3 Medtronic MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Medtronic MIS Sacroiliac Joint Fusion Product Portfolio
- 8.2.5 Medtronic Recent Developments
- 8.3 Zimmer Biomet
- 8.3.1 Zimmer Biomet Company Information
- 8.3.2 Zimmer Biomet Business Overview
- 8.3.3 Zimmer Biomet MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Zimmer Biomet MIS Sacroiliac Joint Fusion Product Portfolio
- 8.3.5 Zimmer Biomet Recent Developments
- 8.4 Orthofix
- 8.4.1 Orthofix Company Information
- 8.4.2 Orthofix Business Overview
- 8.4.3 Orthofix MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Orthofix MIS Sacroiliac Joint Fusion Product Portfolio
- 8.4.5 Orthofix Recent Developments
- 8.5 Zyga Technology
- 8.5.1 Zyga Technology Company Information
- 8.5.2 Zyga Technology Business Overview
- 8.5.3 Zyga Technology MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Zyga Technology MIS Sacroiliac Joint Fusion Product Portfolio
- 8.5.5 Zyga Technology Recent Developments
- 8.6 Xtant Medical
- 8.6.1 Xtant Medical Company Information
- 8.6.2 Xtant Medical Business Overview
- 8.6.3 Xtant Medical MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Xtant Medical MIS Sacroiliac Joint Fusion Product Portfolio
- 8.6.5 Xtant Medical Recent Developments
- 8.7 Globus Medical
- 8.7.1 Globus Medical Company Information
- 8.7.2 Globus Medical Business Overview
- 8.7.3 Globus Medical MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Globus Medical MIS Sacroiliac Joint Fusion Product Portfolio
- 8.7.5 Globus Medical Recent Developments
- 8.8 Life Spine
- 8.8.1 Life Spine Company Information
- 8.8.2 Life Spine Business Overview
- 8.8.3 Life Spine MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Life Spine MIS Sacroiliac Joint Fusion Product Portfolio
- 8.8.5 Life Spine Recent Developments
- 8.9 CoreLink
- 8.9.1 CoreLink Company Information
- 8.9.2 CoreLink Business Overview
- 8.9.3 CoreLink MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.9.4 CoreLink MIS Sacroiliac Joint Fusion Product Portfolio
- 8.9.5 CoreLink Recent Developments
- 8.10 VGI Medical
- 8.10.1 VGI Medical Company Information
- 8.10.2 VGI Medical Business Overview
- 8.10.3 VGI Medical MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.10.4 VGI Medical MIS Sacroiliac Joint Fusion Product Portfolio
- 8.10.5 VGI Medical Recent Developments
- 8.11 SIGNUS Medizintechnik
- 8.11.1 SIGNUS Medizintechnik Company Information
- 8.11.2 SIGNUS Medizintechnik Business Overview
- 8.11.3 SIGNUS Medizintechnik MIS Sacroiliac Joint Fusion Sales, Value and Gross Margin (2021-2026)
- 8.11.4 SIGNUS Medizintechnik MIS Sacroiliac Joint Fusion Product Portfolio
- 8.11.5 SIGNUS Medizintechnik Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 MIS Sacroiliac Joint Fusion Value Chain Analysis
- 9.1.1 MIS Sacroiliac Joint Fusion Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 MIS Sacroiliac Joint Fusion Sales Mode & Process
- 9.2 MIS Sacroiliac Joint Fusion Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 MIS Sacroiliac Joint Fusion Distributors
- 9.2.3 MIS Sacroiliac Joint Fusion Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst